Goldman Sachs Adjusts Price Targets in Med Tech (COV) (EW) (ISRG) (more...)
Get Alerts BCR Hot Sheet
Price: $331.24 --0%
Rating Summary:
10 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
10 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Goldman Sachs adjusted price target on a number of medical technology stocks today.
C.R. Bard Inc. (NYSE: BCR) (Neutral) price target lowered from $85 to $84.
Covidien plc (NYSE: COV) (Buy) price target raised from $59 to $60
Edwards Lifesciences Corp. (NYSE: EW) (Buy) price target raised from $84 to $85
Hill-Rom Holdings, Inc. (NYSE: HRC) (Neutral) price target lowered from $35 to $34
Intuitive Surgical (Nasdaq: ISRG) (Neutral) price target raised from $358 to $362
NuVasive, Inc. (Nasdaq: NUVA) (Neutral) price target lowered from $27 to $25
Stryker Corp. (NYSE: SYK) (Buy) price target lowered from $59 to $58
Varian Medical (NYSE: VAR) (Sell) price target raised from $51 to $53
Zimmer Holdings (NYSE: ZMH) (Sell) price target raised from $56 to $57
C.R. Bard Inc. (NYSE: BCR) (Neutral) price target lowered from $85 to $84.
Covidien plc (NYSE: COV) (Buy) price target raised from $59 to $60
Edwards Lifesciences Corp. (NYSE: EW) (Buy) price target raised from $84 to $85
Hill-Rom Holdings, Inc. (NYSE: HRC) (Neutral) price target lowered from $35 to $34
Intuitive Surgical (Nasdaq: ISRG) (Neutral) price target raised from $358 to $362
NuVasive, Inc. (Nasdaq: NUVA) (Neutral) price target lowered from $27 to $25
Stryker Corp. (NYSE: SYK) (Buy) price target lowered from $59 to $58
Varian Medical (NYSE: VAR) (Sell) price target raised from $51 to $53
Zimmer Holdings (NYSE: ZMH) (Sell) price target raised from $56 to $57
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Deere (DE) PT Raised to $585 at JPMorgan
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share